Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc.

CORD: A Comprehensive Portal into Chordate Olfactory Receptors. GA, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- How animals sense and respond to smells plays a pivotal role in their survival, ...

The world-first scientific breakthrough will enhance understanding of disease development, organ regeneration and cancer ...

Chinese scientists have developed the first 3D model of early mouse embryos, offering new insights into disease development and potential treatments.

Cambridge-based Enhanced Genomics, which is pioneering 3D multi-omics to rapidly identify high-confidence, genetically ...

Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high ...

Abu Dhabi Global Health Week 2025 spotlights digital health and AI as drivers of personalised, preventive care. Here’s how ...

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.

The high-end cellomics market size has grown robustly in recent times, scaling from $2.90 billion in 2024 to $3.15 billion in 2025, marking a compound annual growth rate CAGR of 8.6%. The surge in ...

By 2035, cloud computing, data analytics, and automation powered by AI will propel the worldwide plant phenotyping industry ...

One of the most promising emerging techniques to better understand how disease variants change cellular function is 3D genomics. Analysis of 3D genomic data provides deep insight into the changes ...